Make a nomination to the 2022 Sustainability Award Program

In support of the University of Cincinnati's strategic direction, Next Lives Here, and the goals outlined in the 2019 UC Sustainability + Climate Action Plan, the Sustainability Award Program serves as a celebratory and competitive framework for recognizing UC students, faculty and staff­ who are doing exemplary work in sustainability.

Any member of the UC community is welcome to submit a project that they feel meets the criteria outlined in either the Sustainability Faculty Award, Sustainability Student Award, Sustainability Research Award, or Sustainability Staff Award categories.

The intention of the Sustainability Award is to encourage the UC community to build and enhance our culture of sustainability while also supporting academic excellence, urban impact, and innovation.

Nominations will be accepted on a rolling basis until March 14, 2022, and award recipients will be celebrated during UC Earth Week during April 2022.

To submit a nomination:

1. Visit campuslink.uc.edu/organization/sustainability 

2. Sign in using your UC 6+2 and password

3. One logged in, scroll down until you find the FORMS section.The nomination forms for each award category should be listed separately. Select the form based on nominating someone for the faculty, staff , student, or research award.

4. Fill out the form as instructed. Click NEXT

5. Review your submission, then click SUBMIT.

Related Stories

1

UC experts share Griffin Warrior with America

June 23, 2025

UC Classics researchers Jack Davis and Sharon Stocker reflect on their archaeology careers on the eve of the opening of "The Kingdom of Pylos: Warrior Princes of Ancient Greece" at the prestigious Getty museum in Los Angeles.

2

Multi-institutional team awarded NCI grant to open novel AML...

June 23, 2025

The University of Cincinnati Cancer Center, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Jabez Biosciences are partnering to open a new phase 1 clinical trial studying JBZ-001, a potential new treatment for acute myeloid leukemia, funded by a National Cancer Institute grant.

3

Novel drug achieves high objective response rate in heavily...

June 18, 2025

Cancer Network News highlighted research led by the University of Cincinnati Cancer Center's Zulfa Omer that found a novel drug was generally well tolerated and demonstrated early efficacy in patients with relapsed/refractory chronic lymphocytic leukemia.

Debug Query for this